Vanguard Group Inc Amneal Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 13,728,233 shares of AMRX stock, worth $89.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,728,233
Previous 13,642,387
0.63%
Holding current value
$89.2 Million
Previous $82.8 Million
0.46%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMRX
# of Institutions
178Shares Held
107MCall Options Held
330KPut Options Held
81.9K-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$80.1 Million1.57% of portfolio
-
Fosun International LTD12.3MShares$80 Million54.23% of portfolio
-
Rubric Capital Management LP New York, NY9.54MShares$62 Million1.97% of portfolio
-
Black Rock Inc. New York, NY9.16MShares$59.6 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.07MShares$32.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $984M
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...